Galecto to discontinue development of lung disease treatment

Damora Therapeutics

15/08/2023 12:35

Aug 15 (Reuters) - Galecto Inc  GLTO.O  said on Tuesday
it will dicontinue development of its lung disease treatment
after it failed to meet its primary goal in a mid-stage study.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Arun
Koyyur)
 ((Sriparna.Roy@thomsonreuters.com;))